Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases-Reference-Cited by-同舟云学术

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases

Published:2012-08-24 Issue:2 Volume:159 Page:164-171
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Montalbán Carlos¹,Abraira Víctor,Arcaini Luca²,Domingo-Domenech Eva³,Guisado-Vasco Pablo¹,Iannito Emilio⁴,Mollejo Manuela⁵,Matutes Estella⁶,Ferreri Andrés⁷,Salar Antonio⁸,Rattotti Sara²,Carpaneto Andrea⁹,Pérez Fernández Ricardo¹⁰,Bello José L.¹¹,Hernández Miguel¹²,Caballero Dolores¹³,Carbonell Felix¹⁴,Piris Miguel A.¹⁵,

Affiliation:

1. Department of Internal Medicine; Hospital Ramon y Cajal; IRYCIS; Madrid; Spain

2. Division of Haematology; University of Pavia Medical School; Fondazione IRCCS; Policlinico San Matteo; Pavia; Italy

3. Hospital Duran i Reynals; ICO; Barcelona; Spain

4. Department of Haematology; Ospedale S.G. Moscati; ASL; Taranto; Italy

5. Department of Pathology; Hospital Virgen de la Salud; Toledo; Spain

6. Department of Haemato-Oncology; Royal Marsden Hospital/Institute of Cancer; London; UK

7. Unit of Lymphoid Malignancies; San Raffaele Scientific Institute; Milan; Italy

8. Department of Haematology; Hospital del Mar; Barcelona; Spain

9. UOC Ematologia Ospedale Sant'Anna; Ronciglione ; Viterbo; Italy

10. Department of Oncology; Hospital Gregorio Marañon; Madrid; Spain

11. Department of Haematology; Hospital Universitario, Santiago de Compostela; Spain

12. Department of Haematology; Hospital Universitario de Canarias; Tenerife; Spain

13. Department of Haematology; Hospital Clínico; Salamanca; Spain

14. Hospital General Universitari; Valencia; Spain

15. Department of Pathology; Hospital Marques de Valdecilla; Santander; Spain

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12011/fullpdf

Reference18 articles.

1. Prognosis and prognostic research: validating a prognostic model;Altman;British Medical Journal,2009

2. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles;Arcaini;Cancer,2004

3. Splenic marginal zone lymphoma: a prognostic model for clinical use;Arcaini;Blood,2006

4. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients;Chacon;Blood,2002

5. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures;Cook;Annals of Internal Medicine,2009

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study;Blood Advances;2023-11-15

2. Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review;Cancers;2023-09-06

3. Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study;Blood Advances;2023-08-28

4. Time Trend Analysis of Splenectomy for Splenic Marginal Zone Lymphoma: Declining Surgery, Promising Survival;Annals of Surgical Oncology;2023-07-30

5. Low‐risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study;British Journal of Haematology;2023-06-30